Financial Information

Latest Financial Results


Total revenue of $337.2 million, up 28% from $263.3 million for the prior-year quarter


Net income attributable to ApolloMed of $14.6 million, up 3% from $14.3 million for the prior-year quarter


Earnings per share - diluted ("EPS - diluted") of $0.31

For complete information regarding our financials, see our periodic filings

View the Latest Financials

Balance Sheet

Includes Current Assets, Liabilities and Stockholder's Equity

View Balance Sheet

Income Statement

Includes Total Net Sales, Cost & Expenses and Earnings per share

View Income Statement

Cash Flows

Includes Net Income, Adjustments, and Cash flows from investing & financing activities

View Cash Flow